Showing results (511-520 of 538) with videos related to
Sort By:
Pageof 54
Plos One|August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z Cohen, Allison L Butler, Katrina Millard, et al.Nature Communications|February 19, 2024
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolutionMichael T H Ng, Rowie Borst, Hamez Gacaferi, et al.The Journal of Clinical Investigation|March 12, 2014
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1Mattia Bonsignori, Kevin Wiehe, Sebastian K Grimm, et al.Medrxiv : the Preprint Server for Health Sciences|December 23, 2020
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionalityWilliam Morgenlander, Stephanie Henson, Daniel Monaco, et al.Science Translational Medicine|July 29, 2020
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccinationTodd J Suscovich, Jonathan K Fallon, Jishnu Das, et al.The Journal of Clinical Investigation|February 11, 2021
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionalityWilliam R Morgenlander, Stephanie N Henson, Daniel R Monaco, et al.Science Translational Medicine|July 5, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in BotswanaRoger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi, et al.Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)Stephen R Walsh, Cynthia L Gay, Shelly T Karuna, et al.Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.Pageof 54